Estadísticas de EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP)
Visitas totales
views | |
---|---|
EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP) | 0 |
Visitas totales por mes
views | |
---|---|
enero 2024 | 0 |
febrero 2024 | 0 |
marzo 2024 | 0 |
abril 2024 | 0 |
mayo 2024 | 0 |
junio 2024 | 0 |
julio 2024 | 0 |
Visitas de archivo
views | |
---|---|
EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP).pdf | 13 |